Bactericidal activity of DU-6859a compared to activities of three quinolones, three beta-lactams, clindamycin, and metronidazole against anaerobes as determined by time-kill methodology

被引:21
作者
Spangler, SK
Jacobs, MR
Appelbaum, PC
机构
[1] HERSHEY MED CTR, DEPT PATHOL, HERSHEY, PA 17033 USA
[2] HERSHEY MED CTR, DEPT CLIN MICROBIOL, HERSHEY, PA 17033 USA
[3] CASE WESTERN RESERVE UNIV, CLEVELAND, OH 44106 USA
关键词
D O I
10.1128/AAC.41.4.847
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activities of DU-6859a, ciprofloxacin, levofloxacin, sparfloxacin, piperacillin, piperacillin-tazohactam, imipenem, clindamycin, and metronidazole against 11 anaerobes were tested by the broth microdilution and time-kill methods, DU-6859a was the most active drug tested (broth microdilution MICs, 0.06 to 0.5 mu g/ml), followed by imipenem (MICs, 0.002 to 4.0 mu g/ml). Broth macrodilution MICs were within 3 (but usually 1) dilutions of the broth microdilution MICs. All compounds were bactericidal at the MIC after 48 h; after 21 h, 90% killing was shown for all strains when the compounds were used at four times the MIC. DU-6859a at less than or equal to 0.5 mu g/ml was bactericidal after 38 h.
引用
收藏
页码:847 / 849
页数:3
相关论文
共 16 条
[1]  
Appelbaum P C, 1995, Drugs, V49 Suppl 2, P76
[2]   BETA-LACTAMASE PRODUCTION AND SUSCEPTIBILITY OF UNITED-STATES AND EUROPEAN ANAEROBIC GRAM-NEGATIVE BACILLI TO BETA-LACTAMS AND OTHER AGENTS [J].
JACOBS, MR ;
SPANGLER, SK ;
APPELBAUM, PC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1992, 11 (11) :1081-1093
[3]   THE IN-VITRO ACTIVITY OF A NEW HIGHLY-ACTIVE QUINOLONE, DU-6859A [J].
JOLLEY, A ;
ANDREWS, JM ;
BRENWALD, N ;
WISE, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (05) :757-763
[4]  
KATO N, 1993, 33 INT C ANT AG CHEM, P300
[5]   COMPARATIVE IN-VITRO ACTIVITY OF DU-6859A, A NEW FLUOROQUINOLONE AGENT, AGAINST GRAM-POSITIVE COCCI [J].
KORTEN, V ;
TOMAYKO, JF ;
MURRAY, BE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (03) :611-615
[6]   IN-VITRO COMPARISON OF DU-6859A, A NOVEL FLUOROQUINOLONE, WITH OTHER QUINOLONES AND OPAL CEPHALOSPORINS TESTED AGAINST 5086 RECENT CLINICAL ISOLATES [J].
MARSHALL, SA ;
JONES, RN ;
MURRAY, PR ;
WASHINGTON, JA ;
ALLEN, SD ;
GERLACH, EH ;
ERWIN, ME .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 (06) :877-884
[7]   IN-VITRO ACTIVITY OF DU-6859A, A NEW FLUOROCYCLOPROPYL QUINOLONE [J].
MARSHALL, SA ;
JONES, RN .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (12) :2747-2753
[8]   IN-VITRO ANTIBACTERIAL ACTIVITY OF DU-6859A, A NEW FLUOROQUINOLONE [J].
NAKANE, T ;
IYOBE, S ;
SATO, K ;
MITSUHASHI, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (12) :2822-2826
[9]  
National Committee for Clinical Laboratory Standards, 1993, NCCLS PUBLICATION
[10]   SUSCEPTIBILITIES OF 123 STRAINS OF XANTHOMONAS-MALTOPHILIA TO 8 BETA-LACTAMS (INCLUDING BETA-LACTAM BETA-LACTAMASE INHIBITOR COMBINATIONS) AND CIPROFLOXACIN TESTED BY 5 METHODS [J].
PANKUCH, GA ;
JACOBS, MR ;
RITTENHOUSE, SF ;
APPELBAUM, PC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (10) :2317-2322